TIGIT inhibition and lenalidomide synergistically promote anti-myeloma immune responses after stem cell transplantation in mice
Ontology highlight
ABSTRACT: TIGIT inhibition and lenalidomide synergistically promote anti-myeloma immune responses after stem cell transplantation in mice
PROVIDER: PRJNA909211 | ENA |
REPOSITORIES: ENA
ACCESS DATA